Franklin Genomic Advancements ETF is a ETF series of Franklin Templeton ETF Trust (series S000067393). Net assets $21.4M as of 2026-03-31.
Showing 15 of 122 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Guardant Health Inc | GH | $1.5M | 676.96% |
| Guardant Health Inc | — | $1.5M | 676.96% |
| NATERA INC | NTRA | $1.4M | 664.95% |
| NATERA INC | — | $1.4M | 664.95% |
| Krystal Biotech Inc | — | $1.1M | 532.13% |
| Krystal Biotech Inc | KRYS | $1.1M | 532.13% |
| United Therapeutics Corporation | — | $996K | 464.50% |
| United Therapeutics Corporation | UTHR | $996K | 464.50% |
| Insmed Inc | INSM | $970K | 452.28% |
| Insmed Inc | — | $970K | 452.28% |
| Bridgebio Pharma Inc | BBIO | $905K | 422.15% |
| Bridgebio Pharma Inc | — | $905K | 422.15% |
| Ligand Pharmaceuticals Incorporated | LGND | $757K | 353.18% |
| Ligand Pharmaceuticals Incorporated | — | $757K | 353.18% |
| AstraZeneca PLC | — | $729K | 339.78% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $21.4M |
| 2025-12-31 | $21.8M |
| 2025-09-30 | $17.0M |
| 2025-06-30 | $11.1M |
| 2025-03-31 | $10.8M |
| 2024-12-31 | $13.0M |
| 2024-09-30 | $9.7M |
| 2024-06-30 | $9.5M |